Ali Reza Derakhshan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ali Reza Derakhshan has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Amir Mohammad Hashem Asnaashari
Department of Internal Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
2 shared publications - Majid Khadem-Rezaiyan
Department of Community Medicine, Medical School, Mashhad University of Medical Sciences, Mashhad, Iran
2 shared publications - Majid Mirsadraee
Department of Internal medicine, Faculty of Medicine, Islamic Azad University-Mashhad Branch, Mashhad, Iran
2 shared publications - Roshanak Salari
Department of pharmaceutical sciences in Persian Medicine, School of Persian and Complementary Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
2 shared publications - Shabnam Jalali
Department of Internal Medicine, Medical Student, Mashhad University of Medical Sciences
2 shared publications - Shahin Saeidinejat
MD, PhD of Traditional Persian Medicine, School of Persian and Complementary Medicine, Mashhad University of Medical Sciences
2 shared publications
Latest Publications
- 20 July 2026
- Published by Bentham Science Publishers Ltd. in Current Drug Discovery Technologies
- Vol. 23, 1-5
Honey–Thyme Oxymel as an Adjunctive Therapy for Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis: A Pediatric Case Report
Background: Chronic Pseudomonas aeruginosa infection is one of the major chal-lenges in the management of cystic fibrosis (CF) and is often associated with reduced lung function and increased complications. With the rising trend of antibiotic resistance, research-ers' attention has increasingly shifted toward complementary therapies. In this case report, the use of honey–thyme oxymel, a traditional Persian medicine preparation, was evaluated as an adjunctive treatment in a pediatric patient with CF. Case Presentation: The patient was an 11-year-old girl diagnosed with CF in infancy who had been affected by chronic P. aeruginosa infection for the past eight years. Despite strict adher-ence to standard antibiotic regimens, her throat cultures consistently remained positive. Anti-microbial susceptibility testing demonstrated resistance to multiple antibiotics. In addition to standard CF treatment, including inhaled and oral medications, vitamins, and chest physio-therapy, oral honey–thyme oxymel was added to her regimen at a dose of 5 mL twice daily for two months. Throat cultures obtained in the second, fourth, and sixth months were all negative for P. aeruginosa, representing the first microbiological eradication in the past eight years. Clinically, during six months of follow-up, the patient experienced easier sputum expectora-tion, fewer episodes of dyspnea, and no need for hospitalization. Her pulmonary function also showed significant improvement, with FEV₁ increasing from 73.3% to 83.2% in the second month. The treatment was generally well tolerated, with only a mild, transient cough reported as an adverse effect. Conclusion: This case suggests that adjunctive use of honey–thyme oxymel may be effective in achieving microbiological eradication and improving symptoms in patients with CF. How-ever, given the nature of a case report and the concurrent continuation of standard therapy, these improvements cannot be definitively attributed solely to oxymel consumption. There-fore, further studies, particularly controlled clinical trials, are warranted to accurately evaluate the safety and efficacy of this intervention.
- 20 July 2026
- Published by Bentham Science Publishers Ltd. in Current Drug Discovery Technologies
- Vol. 23, 1-5
Honey–Thyme Oxymel as an Adjunctive Therapy for Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis: A Pediatric Case Report
Background: Chronic Pseudomonas aeruginosa infection is one of the major chal-lenges in the management of cystic fibrosis (CF) and is often associated with reduced lung function and increased complications. With the rising trend of antibiotic resistance, research-ers' attention has increasingly shifted toward complementary therapies. In this case report, the use of honey–thyme oxymel, a traditional Persian medicine preparation, was evaluated as an adjunctive treatment in a pediatric patient with CF. Case Presentation: The patient was an 11-year-old girl diagnosed with CF in infancy who had been affected by chronic P. aeruginosa infection for the past eight years. Despite strict adher-ence to standard antibiotic regimens, her throat cultures consistently remained positive. Anti-microbial susceptibility testing demonstrated resistance to multiple antibiotics. In addition to standard CF treatment, including inhaled and oral medications, vitamins, and chest physio-therapy, oral honey–thyme oxymel was added to her regimen at a dose of 5 mL twice daily for two months. Throat cultures obtained in the second, fourth, and sixth months were all negative for P. aeruginosa, representing the first microbiological eradication in the past eight years. Clinically, during six months of follow-up, the patient experienced easier sputum expectora-tion, fewer episodes of dyspnea, and no need for hospitalization. Her pulmonary function also showed significant improvement, with FEV₁ increasing from 73.3% to 83.2% in the second month. The treatment was generally well tolerated, with only a mild, transient cough reported as an adverse effect. Conclusion: This case suggests that adjunctive use of honey–thyme oxymel may be effective in achieving microbiological eradication and improving symptoms in patients with CF. How-ever, given the nature of a case report and the concurrent continuation of standard therapy, these improvements cannot be definitively attributed solely to oxymel consumption. There-fore, further studies, particularly controlled clinical trials, are warranted to accurately evaluate the safety and efficacy of this intervention.
- 1 November 2024
- Published by Bentham Science Publishers Ltd. in Current Drug Discovery Technologies
- Vol. 21 (6) , 1-17
Spinacia Oleracea: Exploring the Therapeutic Potential in Persian Medicine and Modern Pharmacology
Background: Spinach is a widely cultivated dark leafy vegetable highly regarded for its medicinal properties in traditional Persian medicine. It is rich in vitamins, minerals, flavonoids, carotenoids, and other bioactive compounds, and this review aims to explore the historical applications of spinach in Persian medicine and juxtapose them with current scientific evidence. Despite its historical significance, there remains a need to comprehensively evaluate and integrate traditional knowledge with modern research on the therapeutic benefits of spinach. Methods: To achieve this, a comprehensive search was conducted in Persian medicine references and scientific databases to gather information on the traditional uses, chemical composition, and pharmacological effects of spinach. Studies that met the inclusion criteria were meticulously categorized, and relevant data were analyzed to draw insightful comparisons. Results: Persian medicine describes spinach as a nutrient-rich, laxative, and fast-digesting agent with therapeutic effects on inflammation, lung diseases, back pain, sore throats, jaundice, urinary disorders, joint pain, eye inflammation, insomnia, dementia, and more. Modern studies have substantially corroborated these traditional uses, revealing that spinach possesses antioxidant, anti-inflammatory, anti-cancer, blood sugar-lowering, lipid-lowering, anti-obesity, neurological, ocular, and musculoskeletal effects. Conclusion: Spinach exhibits a wide range of beneficial effects on various health conditions. Its widespread availability, low cost, and exceptional nutritional richness position it as a promising candidate for further investigation. Future studies should explore the clinical effectiveness of spinach in various diseases, while taking into consideration the principles emphasized in Persian medicine to guide research and inform therapeutic strategies.
- 1 November 2024
- Published by Bentham Science Publishers Ltd. in Current Drug Discovery Technologies
- Vol. 21 (6) , 1-17
Spinacia Oleracea: Exploring the Therapeutic Potential in Persian Medicine and Modern Pharmacology
Background: Spinach is a widely cultivated dark leafy vegetable highly regarded for its medicinal properties in traditional Persian medicine. It is rich in vitamins, minerals, flavonoids, carotenoids, and other bioactive compounds, and this review aims to explore the historical applications of spinach in Persian medicine and juxtapose them with current scientific evidence. Despite its historical significance, there remains a need to comprehensively evaluate and integrate traditional knowledge with modern research on the therapeutic benefits of spinach. Methods: To achieve this, a comprehensive search was conducted in Persian medicine references and scientific databases to gather information on the traditional uses, chemical composition, and pharmacological effects of spinach. Studies that met the inclusion criteria were meticulously categorized, and relevant data were analyzed to draw insightful comparisons. Results: Persian medicine describes spinach as a nutrient-rich, laxative, and fast-digesting agent with therapeutic effects on inflammation, lung diseases, back pain, sore throats, jaundice, urinary disorders, joint pain, eye inflammation, insomnia, dementia, and more. Modern studies have substantially corroborated these traditional uses, revealing that spinach possesses antioxidant, anti-inflammatory, anti-cancer, blood sugar-lowering, lipid-lowering, anti-obesity, neurological, ocular, and musculoskeletal effects. Conclusion: Spinach exhibits a wide range of beneficial effects on various health conditions. Its widespread availability, low cost, and exceptional nutritional richness position it as a promising candidate for further investigation. Future studies should explore the clinical effectiveness of spinach in various diseases, while taking into consideration the principles emphasized in Persian medicine to guide research and inform therapeutic strategies.
- Open Access
- 30 June 2023
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 26 (2) , 124-138
Efficacy of Herbal Medicines on Lung Function in Asthma: a systematic review and meta-analysis of randomized controlled trials
Alireza Derakhshan, Masoumeh Sadeghi, Amir-Mohammad-Hashem Asnaashari, Mohsen Dehghani, Roshanak Salari, Majid Khadem-Rezaiyan, Majid Mirsadraee, Shahin Saeidinejat, Shima Jalali, Shabnam Jalali. J Pharmacopuncture 2023;26:124-38. https://doi.org/10.3831/KPI.2023.26.2.124
- 30 June 2023
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 26 (2) , 124-138
Open AccessEfficacy of Herbal Medicines on Lung Function in Asthma: a systematic review and meta-analysis of randomized controlled trials
Alireza Derakhshan, Masoumeh Sadeghi, Amir-Mohammad-Hashem Asnaashari, Mohsen Dehghani, Roshanak Salari, Majid Khadem-Rezaiyan, Majid Mirsadraee, Shahin Saeidinejat, Shima Jalali, Shabnam Jalali. J Pharmacopuncture 2023;26:124-38. https://doi.org/10.3831/KPI.2023.26.2.124
- Open Access
- 30 September 2022
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 25 (3) , 233-241
The Effect of Glasthma Syrup in Asthma: a study protocol for a triple-blind randomized controlled trial
Ali Reza Derakhshan, Shahin Saeidinejat, Majid Khadem-Rezaiyan, Amir-Mohammad-Hashem Asnaashari, Majid Mirsadraee, Roshanak Salari, Farahzad Jabbari-Azad, Shima Jalali, Shabnam Jalali. J Pharmacopuncture 2022;25:233-41. https://doi.org/10.3831/KPI.2022.25.3.233
- 30 September 2022
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 25 (3) , 233-241
Open AccessThe Effect of Glasthma Syrup in Asthma: a study protocol for a triple-blind randomized controlled trial
Ali Reza Derakhshan, Shahin Saeidinejat, Majid Khadem-Rezaiyan, Amir-Mohammad-Hashem Asnaashari, Majid Mirsadraee, Roshanak Salari, Farahzad Jabbari-Azad, Shima Jalali, Shabnam Jalali. J Pharmacopuncture 2022;25:233-41. https://doi.org/10.3831/KPI.2022.25.3.233